Ethanol sclerotherapy for endometriomas: ready for prime time?

Nasab S, Susan Nasab, Bedrick BS, Bronwyn S. Bedrick, Christianson MS, Mindy S. Christianson
Fertility and sterility · 2021 · vol. 115(1) , pp. 100–101 · doi:10.1016/j.fertnstert.2020.10.035 · PMID:33413956 · W3118720504
Other OA: closed CC0 ⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This review examines the efficacy and safety of ethanol sclerotherapy for treating ovarian endometriomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Ovarian Diseases Ovarian Diseases Ethanol Ethanol Female Female Humans Humans Sclerotherapy Sclerotherapy Sclerotherapy

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (5)

Cited by (10)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:29:38.852509+00:00
License: CC0 · commercial use OK